Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
Like malignant fibrous histiocytoma (MFH), dedifferentiated liposarcoma represents a distinct subtype of liposarcoma and is characterized by an abrupt transition from well-differentiated liposarcoma (WDL) to highgrade dedifferentiated liposarcoma (DDL) . In addition, specific cytogenetic aberrations support the close biological relationship between WDL and DDL. Recent observations indicated the significance of cell cycle aberrations in tumor progression from the low-malignant, well differentiated to its dedifferentiated form, the prognosis of which is poor. Thus, alterations of mdm2 and p53 genes belong to the most frequently reported alterations in these two subtypes of liposarcoma. In previous investigations, we reported that loss of heterozygosity at the Rb gene locus, telomerase activity, hTERT, and c-Myc expression were associated with tumor progression in liposarcomas. In this study, we report on a case of a WD/DDL, in which both tumor components were separated using laser microdissection (P.A.L.M.) for the investigation of hTERT mRNA expression on a LightCycler. Macroscopically selected and histologically proven cryosections of low malignant and highly malignant tumor areas were cytogenetically investigated to confirm the diagnosis and to find additional chromosomal alterations with tumor progression.
Schneider-Stock
Regine
R
Department of Pathology, Otto-von-Guericke University, Magdeburg, Germany. Regine.Schneider-Stock@medizin.uni-magdeburg.de
Gerresheim
F
F
Kolin-Gerresheim
I
I
Meyer
F
F
Jäger
V
V
Epplen
J T
JT
Roessner
A
A
Boltze
C
C
D000368:Aged; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000032:analysis* / Q000302:isolation & purification; D004268:DNA-Binding Proteins; D018450:Disease Progression; D004210:Dissection / Q000379:methods; D020869:Gene Expression Profiling; D006801:Humans; D007834:Lasers; D008080:Liposarcoma / Q000235:genetics* / Q000473:pathology; D008297:Male; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis*; D019098:Telomerase / Q000235:genetics; D013899:Thoracic Neoplasms / Q000235:genetics* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D014158:Transcription, Genetic
D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D019098:Telomerase